Latest Strategic Investments News

Tolu Minerals reports significant progress at its Tolukuma Gold Mine, unveiling infrastructure upgrades and a $14.3 million exploration program aimed at boosting production and extending mine life.

Parkway Corporate Limited reported a strong quarter with $4.22 million in revenue and $0.47 million EBITDA, driven by a major wastewater contract and progress in its innovative Queensland Brine Solutions technology.

Spectur Limited reports a positive operating cash flow for Q4 FY25, driven by revenue growth and cost-cutting, alongside strategic investments in cloud and connectivity technology.

Pilbara Minerals delivered robust FY25 results, completing key expansions and beating production guidance, while setting a cost-focused FY26 plan amid ongoing lithium price volatility.

Entertainment Rewards Ltd reports a 6.1% revenue increase in Q4 FY25, driven by growth in key programs and a new $2.5 million loan facility, while narrowing its operating loss.

PolyNovo Limited reports a robust FY25 with nearly 29% sales growth, a significant cash increase to A$33.5 million, and expanding global market presence. The company’s strategic investments and product innovations signal strong momentum ahead.

Centuria Capital No. 2 Fund confirms full compliance with note terms and stable loan positions in its Q4 FY25 report, reassuring investors amid a steady operational quarter.

Holista Colltech reported steady customer receipts and a 38% surge in dietary supplement sales for 2QFY25, while progressing its high-value nano-collagen business and refreshing its leadership team.

ASF Group Limited reported a stable cash position of $1.3 million as of June 2025, accepted a takeover offer for its stake in Rey Resources, and continued to develop its innovative technology and biotech investments.

Black Dragon Gold has entered a critical public consultation phase for its Salave Gold Project’s land use change, marking a key step in its strategic project application amid local government opposition and strong community backing.

SomnoMed reports a robust Q4 FY25 with 25% revenue growth and a milestone of treating over 1 million patients, while gearing up for significant capacity expansion and clinical advancements.

Elementos Limited has delivered a robust Definitive Feasibility Study for its Oropesa Tin Project in Spain, secured a $5 million strategic investment from Metals X, and progressed exploration at its Cleveland Tin Project in Tasmania.